Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 870 participants.
Also called NCT06591351
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 870 participants
- Sponsor
- Registry
-
NCT06591351
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Unknown status
Technical summary
Registry record NCT06591351. Randomized; double masking; primary purpose treatment. Start 2022-05-01 (actual); primary completion 2024-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Cilostazol 100 MG
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06591351- Content hash
af58dfaeb0ef99a4f1dc075b813f2025e28a3256d489cd3dfc01977232cdf88d